Mito BioPharma
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Mito BioPharma is a biopharmaceutical company that develops small-molecule mitochondrial modulators to treat metabolic and liver-based diseases such as NASH, type 2 diabetes, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mito BioPharma Comparables
Compare Mito BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Equator Therapeutics | 86% | |
| MitoRx Therapeutics | 83% | |
| Abarceo Pharma | 80% |
Mito BioPharma Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 42% MoM.
- Jul 28, 2026
Monthly visitors increased 253% MoM.
Mito BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mito BioPharma's valuation, stock price, and market status.
Is Mito BioPharma a public or private company?
Mito BioPharma is a private company.
What is the current stock price of Mito BioPharma?
Mito BioPharma is a private company, so its shares have no public market price. Caplight tracks Mito BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mito BioPharma worth (valuation)?
Valuation information for Mito BioPharma is not publicly available.
Can I buy Mito BioPharma stock?
Mito BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mito BioPharma's last funding round?
Funding round information for Mito BioPharma is not publicly available.
Who are the main investors in Mito BioPharma?
Investor information for Mito BioPharma is not publicly disclosed.
Will Mito BioPharma IPO soon?
No public IPO plans have been announced for Mito BioPharma.
How can I track Mito BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in Mito BioPharma's shares on secondary markets.